| Patents for C07D 267 - Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one oxygen atom as the only ring hetero atoms (2,022) |
|---|
| 03/06/2007 | US7186518 Method and composition useful for determining FK 506 |
| 03/01/2007 | WO2007024501A2 Nitric oxide-releasing biodegradable polymers useful as medical devices and coatings therefore |
| 03/01/2007 | WO2005030711A3 Bridged macrocyclic module compositions |
| 02/21/2007 | EP1753752A1 Highly selective novel amidation method |
| 02/20/2007 | CA2119745C Nonpeptidyl integrin inhibitors having specificity for gpiibiiia receptor |
| 02/15/2007 | US20070037784 Ring structures C6.C6.C13N and C6.C6.C12NO |
| 02/13/2007 | US7176195 Treatment of nocturnal enuresis, nocturia, polyuria resulting from central diabetes insipidus, urinary incontinence or bleeding disorders such a hemophilia |
| 02/13/2007 | CA2265660C Process of production of 4-substituted-3-halogeno-1,4-benzoxazepine derivative and salts thereof |
| 01/24/2007 | CN1900077A New polymorphous forms of rifaximin, processes for their production and use thereof in the medicinal preparations |
| 01/18/2007 | US20070015745 e.g. 4-[4-(2-hydroxy-3-(4-hydroxy-3-(methylsulphonylamino)phenoxy)propylamino)cyclohexyl]benzoic acid; beta-3 adrenergic receptor agonist; antidiabetic agent, obesity |
| 01/17/2007 | EP1742707A2 Treatment of cns disorders using cns target modulators |
| 01/17/2007 | CN1898219A Novel keto-oxadiazole derivatives as cathepsin inhibitors |
| 01/11/2007 | WO2007004960A1 New compounds, process for their preparation, intermediates, pharmaceutical compositions and their use in the treatment of 5-ht6 mediated disorders such as alzheimer’s desease, cognitive disorders, cognitive impairment associated with schizophrenia, obesity and parkinson’s disease |
| 01/11/2007 | WO2007004959A1 New compounds, process for their preparation, intermediates, pharmaceutical compositions and their use in the treatment of 5-ht6 mediated disorders such as alzheimer's disease, cognitive disorders, cognitive impairment associated with schizophrenia, obesity and parkinson's disease |
| 01/11/2007 | WO2006117669B1 Amide resorcinol compounds |
| 01/10/2007 | EP1740558A1 Benzoxazocines and their therapeutic use as monoamine reuptake inhibitors |
| 01/10/2007 | CN1894224A A process for the resolution of nefopam |
| 01/02/2007 | US7157457 Compounds useful in the treatment of inflammatory diseases |
| 01/02/2007 | US7157447 Useful for treating HIV infection and AIDS |
| 12/27/2006 | EP1597260B1 Triazole compounds useful in therapy |
| 12/27/2006 | CN1886407A Bicyclic pyrazolyl and imidazolyl compounds and uses thereof |
| 12/21/2006 | US20060287293 1-(4-{ethyl-[2-(4-methanesulfonylphenyl)-1-methylethyl]amino}butyl)-4-methanesulfonyl-[1,4]diazepan-2-one; repiratory system disorders: asthma and chronic obstructive pulmonary disease; nervous system, muscular,urogenital, gastrointestinal disorders; antiallergens; side effect reduction |
| 12/19/2006 | US7151097 Bicyclic pyrazolyl and imidazolyl compounds and uses thereof |
| 12/14/2006 | WO2006132295A1 Regulator of aldosterone receptor |
| 12/13/2006 | EP1730525A1 Immunoassays for everolimus |
| 12/12/2006 | US7148347 Reacting macrocyclic amide compound with hydroxy naphthalene or hydroxy quinoline derivative in a polar non-protic organic solvent in the presence of an organic or inorganic base |
| 11/29/2006 | EP1725565A2 Fused heterotricyclic compounds as inhibitors of 17b-hydroxysteroid dehydrogenase 3 |
| 11/28/2006 | US7141560 For use as analgesic or sedative; treating sleep disorders |
| 11/28/2006 | CA2113603C Tricyclic condensed heterocyclic compounds, their production and use |
| 11/15/2006 | EP1324991B1 Compounds useful in the treatment of inflammatory diseases |
| 11/14/2006 | CA2128955C Tricyclic benzazepine vasopressin antagonists |
| 11/09/2006 | WO2006117669A1 Amide resorcinol compounds |
| 11/09/2006 | US20060252930 Fki-1366 substances and process for producing the same |
| 11/09/2006 | CA2605985A1 Amide resorcinol compounds |
| 11/08/2006 | EP1021190B1 Amid derivatives as growth hormone release promotors |
| 11/08/2006 | CN1283622C Cyclohexyl (alkyl)-propanolamines, preparation method and pharmaceutical compositions containing same |
| 11/07/2006 | US7132551 Piperidine and azepine derivatives; anxiolytic, analgesic, antidepressant, antiemetic, antiinflammatory, and hypotensive agents; sexual and psychological disorders; Alzheimer*s, Parkinson*s, Lesche-Nyhane, Wilson*s, and Tourette*s syndrome |
| 11/02/2006 | US20060247448 zearalenone-like macrolides, used to to inhibit nuclear factor kappa-beta (NF- kappa B) activation, as sucnscreen agents and in the treatment of inflammatory or autoimmune disorders and disorders involving malignancy or increased angiogenesis |
| 11/01/2006 | CN1854128A Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds |
| 10/31/2006 | US7129346 Crown ether chelators, including fluorescent derivatives chelate metal cations; detection, discrimination and quantification of metal cations |
| 10/31/2006 | US7129228 Heterocyclic analgesic compounds and methods of use thereof |
| 10/31/2006 | CA2350560C Novel type condensed pyridazinone compounds |
| 10/26/2006 | WO2006036941A3 Specific kinase inhibitors |
| 10/26/2006 | US20060241096 Agent for preventing or treating organ functional disorders and organ dysfunction |
| 10/24/2006 | CA2261848C Cell adhesion inhibitors |
| 10/19/2006 | WO2005103041A3 Treatment of cns disorders using cns target modulators |
| 10/17/2006 | US7122662 Tricyclic compound having spiro union |
| 10/17/2006 | US7122525 Targeted therapeutics and uses thereof |
| 10/11/2006 | CN1279044C Non-steroidal progesterone receptor modulators |
| 10/03/2006 | US7115735 Which produces N-alkyl-L-alanine from pyruvic acid and alkylamine or dialkylamine using NADPH and/or NADH as coenzyme; biosynthesis |
| 09/28/2006 | WO2006101496A1 Novel anti-arrythmic and heart failure drugs that target the leak in the ryanodine receptor (ryr2) |
| 09/28/2006 | CA2601541A1 Novel anti-arrythmic and heart failure drugs that target the leak in the ryanodine receptor (ryr2) |
| 09/21/2006 | WO2006097449A1 N-hydroxyamides omega-substituted with tricyclic groups as histone deacetylase inhibitors, their preparation and use in pharmaceutical formulations |
| 09/21/2006 | CA2600521A1 N-hydroxyamides omega-substituted with tricyclic groups as histone deacetylase inhibitors, their preparation and use in pharmaceutical formulations |
| 09/20/2006 | CN1835936A Macrocyclic beta-secretase inhibitors for the treatment of alzheimer's disease |
| 09/19/2006 | US7109233 substituted 1,1,4-1l6-trioxo[1,2]thiazepan-4-ylamide-derived protease inhibitors which inhibit the likes of cathepsin K; treating osteoporosis, osteo- and rheumatoid arthritis and periodontal disease; inhibiting excessive cartilage or matrix degradation |
| 09/14/2006 | WO2006095187A1 Benzoxazocines and their therapeutic use |
| 09/14/2006 | CA2600254A1 Benzoxazocines and their therapeutic use |
| 09/13/2006 | EP1406881B1 11-piperazinyldibenzo(b,f)(1,4)oxazepines and thiazepines as atypical antipsychotic agents having low affinity for the d2 receptor |
| 09/13/2006 | CN1832934A Benzoxazepine-based compound |
| 09/08/2006 | WO2006034414A3 Loxapine analogs and methods of use thereof |
| 09/07/2006 | US20060199795 e.g. 2-[3,5-trans-5-(3-aminophenyl)-7-chloro-1-neopentyl-2-oxo-1,2,3,5-tetrahydro-4,1-benzoxazepin-3-yl]-N-(2-fluorobenzyl)acetamide; G-protein-coupled receptor (TGR5) agonist; central nervous system diseases; antiinflammatory agent; learning enhancement; angina pectoris, arrhythmia, bronchial asthma |
| 09/06/2006 | CN1273463C (1-phenacy-3-phenyl-3-piperidylethyl)piperidine derivatives, method for production thereof and pharmaceutical compositions containing the same |
| 08/24/2006 | WO2006004774A3 Laulimalide analogues as therapeutic agents |
| 08/24/2006 | US20060189657 Difluoroalkyl-subsituted amides such as morpholine-4-carboxylic acid {(S)-1-[(S)-1-(3-cyclopropyl-1,2,4-oxadiazole-5-carbonyl)-propylcarbamoyl]-3,3-difluoro-butyl}-amide; diseases associated wtih cathepsin S, K, and B such as neurodegenerative diseases, osteoporosis, emphysema, viral infection, cancer |
| 08/24/2006 | CA2597306A1 Compounds and uses thereof |
| 08/23/2006 | EP1692118A2 A process for the resolution of nefopam |
| 08/23/2006 | CN1823036A Novel dibenzo[B,F]oxepine-10-carboxamides and pharmaceutical uses thereof |
| 08/22/2006 | US7094778 Nervous system disorders; muscular disorders; urogenital disorders; gastrointestinal disorders; repiratory system disorders; antiallergens; side effect reduction |
| 08/17/2006 | WO2006021213A3 Vasopressin v1a antagonists |
| 08/15/2006 | US7091196 triazoles and optionally carrier mixtures used for prohylaxis of infections, as antiproliferative agents, fungicides, bactericides, parasiticides, viricides, antiinflammatory agents and/or prokinetic agents (gastrointestinal modulatory) |
| 08/09/2006 | EP1687283A2 Method and composition useful for determining fk 506 |
| 08/03/2006 | WO2006061136A3 Malonamide derivatives as inhibitors of gamma-secretase for the treatment of alzheimer’s disease |
| 08/03/2006 | US20060172985 Internal 1, 15-lactones of fluprostenol and related prostaglandin F2a analogs and their use in the treatment of glaucoma and intraocular hypertension |
| 07/27/2006 | WO2006078724A2 Macrocyclic analogs for the treatment of immunoregulatory disorders and respiratory diseases |
| 07/27/2006 | US20060166965 Atypical antipsychotic agents having low affinity for the D2 receptor |
| 07/27/2006 | CA2601380A1 Macrocyclic analogs for the treatment of immunoregulatory disorders and respiratory diseases |
| 07/26/2006 | EP1682524A1 Novel keto-oxadiazole derivatives as cathepsin inhibitors |
| 07/25/2006 | US7081454 Anticancer agents |
| 07/20/2006 | WO2006037775A8 Enantiopure heterocyclic compound useful for the preparation of peptides which can be potentially used as medicaments |
| 07/20/2006 | US20060160838 Topically active FK520 and FK506 analogs; calcineurin inhibitorse useful in the treatment of immunoregulatory and respiratory disorders; lung or heart transplantation; antiinflammatory agents; bronchitis; asthma; immunosuppressants; autoimmune diseases eosinophil-related diseases |
| 07/13/2006 | US20060155119 Ascomycin crystalline forms and preparation thereof |
| 07/06/2006 | WO2006046123A3 Conjugates with anti-inflammatory activity |
| 07/06/2006 | US20060149057 Method of purifying macrolides |
| 07/06/2006 | US20060147540 Non-hygroscopic and powdery amorphous pimecrolimus |
| 07/05/2006 | CN1796389A Antibacterial compound A-13, and application in preparing antibacterial drug |
| 06/29/2006 | US20060142264 Novel amide derivatives |
| 06/29/2006 | US20060141548 Immunoassays for everolimus |
| 06/28/2006 | CN1794997A 2,3,4,5-tetrahydrobenzo[f][1,4]oxazepine-5-carboxylic acid amide derivatives as gamma-secretase inhibitors for the treatment of alzheimer's disease |
| 06/28/2006 | CN1261430C Novel benzazepines and related heterocyclic derivatives which are useful as orexin receptor antagonists |
| 06/22/2006 | WO2006065218A1 Novel molecular probes |
| 06/22/2006 | US20060135762 Preventing the deposits of amyloid protein, treating neurodegenerative disease, Alzheimer's disease and Down's Syndrome; {[carbamoyl]cycloalkyl}-N-(2-oxo-5-phenyl((S)-3H-benzo[f]1,4-diazepin-3-yl))- or (2-oxo-5-phenyl((S)-3H-benzo[f]1,4-diazepin-3-yl))-carboxamide |
| 06/20/2006 | US7064121 benzodiazepine derivatives that may be fused to a pyrroline or piperidine ring; e.g., N-[1 (R)-(3-Aminopropylcarbamoyl)-2-(naphthalen-2-yl)ethyl]-3-(5,11-dioxo-2,3-dihydro-1H-(11aS)-pyrrolo[2,1-c][1,4]benzodiazepin-10-yl)propionamide; increasing levels of endogenous growth hormones in humans and animals |
| 06/15/2006 | WO2006061136A2 Malonamide derivatives as inhibitors of gamma-secretase for the treatment of alzheimer’s disease |
| 06/15/2006 | CA2589196A1 Malonamide derivatives as inhibitors of gamma-secretase for the treatment of alzheimer's disease |
| 06/14/2006 | EP1667965A2 Bridged macrocyclic module compositions |
| 06/13/2006 | US7060698 5-alkylaminocarbonyl-substituted, e.g., 4-(1-benzyl-piperidin-4-yl)-2-isopropyl-3-oxo-2,3,4,5-tetrahydro-benzo[f][1,4]oxazepine-5-carboxylic acid tert-butylamide; gamma -secretase inhibitors for the treatment of Alzheimer's disease. |
| 06/07/2006 | EP1373188B1 Alanine 2,6-dialkoxyphenyl ester derivatives as hypnotics |
| 06/06/2006 | US7057036 Pyrrolothiazine and pyrrolothiazepine compounds having serotonin-2 receptor antagonistic and alpha-1-blocking action |
| 06/06/2006 | CA2136903C Acetic acid derivatives |